tranexamic acid has been researched along with Lichen Planus in 2 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Lichen Planus: An inflammatory, pruritic disease of the skin and mucous membranes, which can be either generalized or localized. It is characterized by distinctive purplish, flat-topped papules having a predilection for the trunk and flexor surfaces. The lesions may be discrete or coalesce to form plaques. Histologically, there is a saw-tooth pattern of epidermal hyperplasia and vacuolar alteration of the basal layer of the epidermis along with an intense upper dermal inflammatory infiltrate composed predominantly of T-cells. Etiology is unknown.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oral tranexamic acid has been used in different types of hyperpigmentation disorder, including postinflammatory hyperpigmentation treatment and prevention, lichen planus pigmentosus, ashy dermatosis, and Riehl melanosis in a dose range from 250 mg per day to 1500 mg per day for a period range from 2 weeks to 6 months with variable efficacy and a good safety profile." | 9.41 | Oral tranexamic acid in the treatment of hyperpigmentation disorder beyond melasma: A review. ( Mahjoub, TT; Milibary, HH, 2023) |
| "Our study suggests that tranexamic acid could be an effective treatment for lichen planus pigmentosus with a good safety profile." | 7.96 | [Oral tranexamic acid in the treatment of lichen planus pigmentosus: A prospective study of 20 cases]. ( Chiheb, S; Elfetoiki, FZ; Hali, F; Skalli, H; Zenjari, L, 2020) |
| "Oral tranexamic acid has been used in different types of hyperpigmentation disorder, including postinflammatory hyperpigmentation treatment and prevention, lichen planus pigmentosus, ashy dermatosis, and Riehl melanosis in a dose range from 250 mg per day to 1500 mg per day for a period range from 2 weeks to 6 months with variable efficacy and a good safety profile." | 5.41 | Oral tranexamic acid in the treatment of hyperpigmentation disorder beyond melasma: A review. ( Mahjoub, TT; Milibary, HH, 2023) |
| "Our study suggests that tranexamic acid could be an effective treatment for lichen planus pigmentosus with a good safety profile." | 3.96 | [Oral tranexamic acid in the treatment of lichen planus pigmentosus: A prospective study of 20 cases]. ( Chiheb, S; Elfetoiki, FZ; Hali, F; Skalli, H; Zenjari, L, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mahjoub, TT | 1 |
| Milibary, HH | 1 |
| Zenjari, L | 1 |
| Elfetoiki, FZ | 1 |
| Hali, F | 1 |
| Skalli, H | 1 |
| Chiheb, S | 1 |
1 review available for tranexamic acid and Lichen Planus
| Article | Year |
|---|---|
Oral tranexamic acid in the treatment of hyperpigmentation disorder beyond melasma: A review.
Topics: Antifibrinolytic Agents; Humans; Hyperpigmentation; Lichen Planus; Melanosis; Tranexamic Acid; Treat | 2023 |
1 other study available for tranexamic acid and Lichen Planus
| Article | Year |
|---|---|
[Oral tranexamic acid in the treatment of lichen planus pigmentosus: A prospective study of 20 cases].
Topics: Face; Female; Humans; Hyperpigmentation; Lichen Planus; Lichen Planus, Oral; Male; Middle Aged; Pros | 2020 |